Global Health

What does access to a research paper cost its intended readers? Part two of this series explores purchasing power, publication fees and barriers faced in lower-income countries, then considers green open access, self-archiving and preprints as routes to wider dissemination.

Choosing a journal means thinking beyond impact factors. Part one of this series asks who needs your research, how regional readership and access costs affect its reach, and how authors can consider audiences in low- and middle-income countries when deciding where to publish.

Who gets the opportunity to become an author? Part three of the equitable publishing series explores fair authorship, mentorship and sponsorship, with practical ways to support junior researchers and widen opportunities beyond the colleagues already in our immediate networks.

A September 2020 appraisal of REMAP-CAP's hydrocortisone results in critically ill patients with COVID-19. Dan Horner and Simon Carley explain adaptive trials, Bayesian analysis and organ support outcomes, weighing the findings against early stopping, treatment crossover and the wider corticosteroid evidence.

Iain and Simon review May 2020 on St Emlyn's, including COVID-19 research discussions and venous thromboembolism resources. The written episode notes also connect global health, race and inequality with reflections on privilege and the perspectives emergency clinicians bring to their work.

A May 2020 selection of ten COVID-19 papers, from antibiotic prescribing and healthcare worker testing to antibody assays and public health measures. The reviews also consider intimate partner violence and the needs of people with intellectual disabilities, alongside the limitations of emerging evidence.